Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the dose response, and efficacy of Mapracorat
ophthalmic formulation compared to its vehicle for the prevention of symptoms and signs
associated with allergic conjunctivitis using a conjunctival allergen challenge (CAC) model.